Biosimilars: Perception, cost and the impact on biotech innovation

Pharmaceutical Technology Europe

Volumn 22, Issue 9, 2010, Pages

  Malik, Ameet ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; BEVACIZUMAB; BIOLOGICAL PRODUCT; CETUXIMAB; ETANERCEPT; HUMAN GROWTH HORMONE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

DRUG MARKETING; EUROPE; SHORT SURVEY;

EID: 78651242935     PISSN: 01646826     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (1)

1. The competitive role of biosimilars in the German SHI market for pharmaceuticals (IGES Institute GmbH, data on file at Sandoz, January 2009).